GRACEcast Lung Cancer Audio

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (audio)


Episode Artwork
1.0x
0% played 00:00 00:00
Aug 26 2013 5 mins  
Other Episodes

Dr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.

Download episode Share
Copy URL



Subscribe on Podcast Addict